Related Experiment Videos

Search for agents causing atypical pneumonia in HIV-positive patients by inhibitor-controlled PCR assays

B Tarp1, J S Jensen, L Ostergaard

  • 1Dept of Infectious Diseases, Aarhus University Hospital, Denmark.

Insights

Pneumonia in HIV patients is often caused by Pneumocystis carinii. Atypical agents like Chlamydia, Legionella, and Mycoplasma pneumoniae are rare, but polymerase chain reaction can detect them.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pulmonology

Background:

  • Pneumonia is a frequent complication in patients with acquired immunodeficiency syndrome (AIDS).
  • Pneumocystis carinii pneumonia (PCP) is the leading cause, but atypical pathogens are underdiagnosed due to unreliable antibody testing in human immunodeficiency virus (HIV)-positive individuals.
  • Antibody-based diagnostics are limited in HIV patients with compromised immune responses.

Purpose of the Study:

  • To determine the prevalence of Chlamydia spp., Legionella spp., and Mycoplasma pneumoniae in HIV-infected patients with pneumonia.
  • To evaluate the utility of polymerase chain reaction (PCR) for diagnosing these atypical pathogens in this population.

Main Methods:

  • Retrospective analysis of 103 bronchoalveolar lavage (BAL) fluid samples from 83 HIV-positive patients with pneumonia.
  • Inhibitor-controlled PCR was used to detect Chlamydia spp., Legionella pneumophila, and Mycoplasma pneumoniae.
  • Conventional culture and staining methods were used to identify other microorganisms.

Main Results:

  • Legionella pneumophila was detected in 1% of BAL fluids.
  • Mycoplasma pneumoniae was identified as a co-pathogen in 2% of samples.
  • Chlamydia spp. were not detected in any samples. Pneumocystis carinii and Streptococcus pneumoniae were the most common pathogens identified by culture and staining.

Conclusions:

  • Pneumonia caused by Chlamydia pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae appears to be rare in Danish HIV-infected patients.
  • These atypical agents should be considered in cases of treatment failure, especially when conventional diagnostics are inconclusive.

Related Concept Videos